Listeria monocytogenes as a Vector for Cancer Immunotherapy
Abstract
:Funding
Acknowledgments
Conflicts of Interest
References
- World Health Organization. WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
- Topalian, S.L.; Weiner, G.J.; Pardoll, D.M. Cancer immunotherapy comes of age. J. Clin. Oncol. 2011, 29, 4828–4836. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sharma, P.; Allison, J.P. Immune checkpoint targeting in Cancer Therapy: Toward combination strategies with curative potential. Cell 2015, 161, 205–214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Page, A.; Fusil, F.; Cosset, F.-L. Towards Physiologically and Tightly Regulated Vectored Antibody Therapies. Cancers 2020, 12, 962. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Marhelava, K.; Pilch, Z.; Bajor, M.; Graczyk-Jarzynka, A.; Zagozdzon, R. Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer. Cancers 2019, 11, 1756. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chakrabarty, A.M. Microorganisms and Cancer: Quest for a therapy. J. Bacteriol. 2003, 185, 2683–2686. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bernardes, N.; Seruca, R.; Chakrabarty, A.M.; Fialho, A.M. Microbial-based therapy of cancer: Current progress and future prospects. Bioeng. Bugs 2010, 1, 178–190. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Roberts, B.N.; Chakravarty, D.; Gardner, J., III; Ricke, S.C.; Donaldson, J.R. Listeria monocytogenes Response to Anaerobic Environments. Pathogens 2020, 9, 210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Matereke, L.T.; Okoh, A.I. Listeria monocytogenes virulence, antimicrobial resistance and environmental persistence: A Review. Pathogens 2020, 9, 528. [Google Scholar] [CrossRef] [PubMed]
- Flickinger, J.C., Jr.; Rodeck, U.; Snook, A.E. Listeria monocytogenes as a vector for cancer immunotherapy: Current understanding and progress. Vaccines 2018, 6, 48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Leitão, J.H. Listeria monocytogenes as a Vector for Cancer Immunotherapy. Vaccines 2020, 8, 439. https://doi.org/10.3390/vaccines8030439
Leitão JH. Listeria monocytogenes as a Vector for Cancer Immunotherapy. Vaccines. 2020; 8(3):439. https://doi.org/10.3390/vaccines8030439
Chicago/Turabian StyleLeitão, Jorge H. 2020. "Listeria monocytogenes as a Vector for Cancer Immunotherapy" Vaccines 8, no. 3: 439. https://doi.org/10.3390/vaccines8030439
APA StyleLeitão, J. H. (2020). Listeria monocytogenes as a Vector for Cancer Immunotherapy. Vaccines, 8(3), 439. https://doi.org/10.3390/vaccines8030439